NCCM
HALO icon

Nine Chapters Capital Management’s Halozyme HALO Stock Holding History

Nine Chapters Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-24,500
Closed -$242K – 1057
2014
Q2 		$242K Buy
+24,500
New +$208K 0.02% 783

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nine Chapters Capital Management's HALO Position: Q3 2014 in Review

Nine Chapters Capital Management sold out of Halozyme (HALO) in Q3 2014, closing a stake of 24,500 shares — an estimated $242K sold.

Nine Chapters Capital Management first reported a position in HALO in Q2 2014 and held it in 1 quarter. The position peaked at $242K in Q2 2014. 121 funds tracked by Wall St. Rank hold HALO as of Q3 2014.

  • Nine Chapters Capital Management reported no remaining Halozyme position as of Q3 2014 after selling out during the quarter.
  • Nine Chapters Capital Management sold 24,500 Halozyme shares in Q3 2014, an estimated $242K.
  • Nine Chapters Capital Management first reported a position in Halozyme in Q2 2014 and held it in 1 quarter.
  • Nine Chapters Capital Management's Halozyme position peaked at $242K in Q2 2014.
  • 121 funds tracked by Wall St. Rank held Halozyme as of Q3 2014.

Based on Nine Chapters Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.